Raeymaeckers Steven, Tosi Maurizio, De Mey Johan
Universitair Ziekenhuis Brussel, Laarbeeklaan 101, Jette 1090, Belgium.
Radiology, Vrije Universiteit Brussel, Laarbeeklaan 103, Jette 1090, Belgium.
Radiol Res Pract. 2021 May 21;2021:6614406. doi: 10.1155/2021/6614406. eCollection 2021.
4DCT for the detection of (an) enlarged parathyroid(s) is a commonly performed examination in the management of primary hyperparathyroidism. Protocols are often institution-specific; this review aims to summarize the different protocols and explore the reported sensitivity and specificity of different 4DCT protocols as well as the associated dose.
A literature study was independently conducted by two radiologists from April 2020 until May 2020 using the Medical Literature Analysis and Retrieval System Online (MEDLINE) database. Articles were screened and assessed for eligibility. From eligible studies, data were extracted to summarize different parameters of the scanning protocol and observed diagnostic attributes.
A total of 51 articles were included and 56 scanning protocols were identified. Most protocols use three ( = 25) or four different phases ( = 23). Almost all authors include noncontrast enhanced imaging and an arterial phase. Arterial images are usually obtained 25-30 s after administration of contrast, and less agreement exists concerning the timing of the venous phase(s). A mean contrast bolus of 100 mL is administered at 3-4 mL/s. Bolus tracking is not often used ( = 3). A wide range of effective doses are reported, up to 28 mSv. A mean sensitivity of 81.5% and a mean specificity of 86% are reported.
Many different 4DCT scanning protocols for the detection of parathyroid adenomas exist in the literature. The number of phases does not appear to affect sensitivity or specificity. A triphasic approach, however, seems preferable, as three patterns of enhancement of parathyroid adenomas are described. Bolus tracking could help to reduce the variability of enhancement. Sensitivity and specificity also do not appear to be affected by other scan parameters like tube voltage or tube current. To keep the effective dose within limits, scanning at a lower fixed tube current seems preferable. Lowering tube voltage from 120 kV to 100 kV may yield similar image contrast but would also help lower the dose.
在原发性甲状旁腺功能亢进症的治疗中,利用四维计算机断层扫描(4DCT)检测甲状旁腺增大是一项常用检查。扫描方案通常因机构而异;本综述旨在总结不同的扫描方案,探讨不同4DCT方案报告的敏感性和特异性以及相关剂量。
2020年4月至2020年5月,两名放射科医生独立使用医学文献分析和检索系统在线(MEDLINE)数据库进行文献研究。对文章进行筛选和评估以确定其是否符合要求。从符合要求的研究中提取数据,以总结扫描方案的不同参数和观察到的诊断特征。
共纳入51篇文章,确定了56种扫描方案。大多数方案采用三个(=25)或四个不同时相(=23)。几乎所有作者都包括平扫成像和动脉期。动脉期图像通常在注射造影剂后25 - 30秒获得,而关于静脉期的时间安排,意见分歧较大。以3 - 4毫升/秒的速度注射平均100毫升的造影剂团注。很少使用团注追踪(=3)。报告的有效剂量范围很广,最高可达28毫希沃特。报告的平均敏感性为81.5%,平均特异性为86%。
文献中存在许多用于检测甲状旁腺腺瘤的不同4DCT扫描方案。时相数量似乎不影响敏感性或特异性。然而,三相扫描方法似乎更可取,因为甲状旁腺腺瘤有三种强化模式。团注追踪有助于减少强化的变异性。敏感性和特异性似乎也不受管电压或管电流等其他扫描参数的影响。为使有效剂量在限制范围内,以较低的固定管电流进行扫描似乎更可取。将管电压从120千伏降低到100千伏可能会产生相似的图像对比度,但也有助于降低剂量。